HK1185016A1 - 用於治療和/或預防病理病症的富集有抗 的免疫球蛋白的製劑 - Google Patents

用於治療和/或預防病理病症的富集有抗 的免疫球蛋白的製劑

Info

Publication number
HK1185016A1
HK1185016A1 HK13112530.7A HK13112530A HK1185016A1 HK 1185016 A1 HK1185016 A1 HK 1185016A1 HK 13112530 A HK13112530 A HK 13112530A HK 1185016 A1 HK1185016 A1 HK 1185016A1
Authority
HK
Hong Kong
Prior art keywords
lps
prophylaxis
treatment
immunoglobulin preparation
enriched immunoglobulin
Prior art date
Application number
HK13112530.7A
Other languages
English (en)
Inventor
Tomer Adar
Meir Mizrahi
Gadi Lalazar
Yaron Ilan
Yaacov Ami Ben
Original Assignee
Immuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuron Ltd filed Critical Immuron Ltd
Publication of HK1185016A1 publication Critical patent/HK1185016A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13112530.7A 2010-08-17 2013-11-07 用於治療和/或預防病理病症的富集有抗 的免疫球蛋白的製劑 HK1185016A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37432810P 2010-08-17 2010-08-17
PCT/IB2011/002596 WO2012023051A2 (en) 2010-08-17 2011-08-17 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder

Publications (1)

Publication Number Publication Date
HK1185016A1 true HK1185016A1 (zh) 2014-02-07

Family

ID=45218767

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13112530.7A HK1185016A1 (zh) 2010-08-17 2013-11-07 用於治療和/或預防病理病症的富集有抗 的免疫球蛋白的製劑

Country Status (8)

Country Link
US (1) US9943597B2 (zh)
EP (1) EP2605791B1 (zh)
AU (1) AU2011290478B2 (zh)
CA (1) CA2808361A1 (zh)
DK (1) DK2605791T3 (zh)
ES (1) ES2628032T3 (zh)
HK (1) HK1185016A1 (zh)
WO (1) WO2012023051A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1014774A2 (pt) 2009-04-27 2019-04-16 Immuron Limited preparacao de imunoglobulina enriquecida anti-lps para uso no tratamento e/ou na profilaxia de um disturbio patologico
US20130273074A1 (en) * 2010-10-04 2013-10-17 Immuron Limited Methods and Compositions Using Anti-LPS Ligands for the Treatment and Prevention of Inflammatory Disorders
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
DE102011006809A1 (de) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
AU2012269740A1 (en) * 2011-06-17 2013-01-31 Immuron Limited Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage
WO2014121045A1 (en) * 2013-01-31 2014-08-07 The University Of Maryland, Baltimore Colostrum composition enriched in anti-endotoxin antibodies
EP3452064A4 (en) * 2016-05-06 2019-11-27 Hadasit Medical Research Services And Development COLOSTRUM HYPERIMMUN FOR USE IN MODULATING AND TREATING MAMMALIAN MICROBIOMA-ASSOCIATED DISORDERS
CN108095767B (zh) * 2018-01-19 2020-10-02 无锡海斯凯尔医学技术有限公司 组织炎症活动度检测装置
WO2019220833A1 (ja) * 2018-05-18 2019-11-21 株式会社島津製作所 診断支援システムおよび診断支援装置
US20210269769A1 (en) * 2018-09-20 2021-09-02 Mystem Biotechnologies Inc. Colostrum Derived Stem Cells, Neural Differentiation, Compositions and Supplements for Enhancing Mammalian Health
US20210252149A1 (en) * 2020-02-19 2021-08-19 Anubis Bio Corporation Composition and Methods for Treating Infectious Agents Using Pathogen-specific Antibodies
WO2022011436A1 (en) * 2020-07-17 2022-01-20 Immuron Limited Methods of treating coronavirus infection with bovine-hyperimmune colostrum
US11869650B2 (en) * 2021-01-12 2024-01-09 Tandem Diabetes Care, Inc. Remote access for medical device therapy

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
JPS58154513A (ja) 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho 予防及び治療薬
US4748018A (en) 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
GB9105292D0 (en) 1991-03-13 1991-04-24 Sandoz Ltd Improvements in or relating to organic compounds
ATE234855T1 (de) 1993-09-20 2003-04-15 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
US5397372A (en) 1993-11-30 1995-03-14 At&T Corp. MCVD method of making a low OH fiber preform with a hydrogen-free heat source
PL345208A1 (en) * 1998-05-27 2001-12-03 Gemma Biotechnology Ltd The induction of antiobiotic proteins and peptides by lait/scd14-protein
DE19830607C2 (de) 1998-07-09 2002-08-01 Hte Ag The High Throughput Exp Verfahren zum Nachweis eines Produktes im Abstrom eines katalytischen Materials einer Vielzahl von katalytischen Materialien
EP1485111A4 (en) 2002-03-21 2009-08-19 Anadis Ltd COMPOSITIONS WITH LABELS BIOACTIVE MATERIALS AND Mammalian COLOSTRUM, MANUFACTURING PROCESS AND TREATMENT
GB2405338B (en) 2002-05-21 2006-04-12 Anadis Ltd Composition comprising antibodies for the prophylaxis of respiratory infections
US9701737B2 (en) 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
KR101233648B1 (ko) 2004-09-29 2013-02-15 시즈오카켄 유청 단백, 젖 유래의 항체 또는 항체를 포함하는 기능성조성물 또는 식품
EP2417986A1 (en) 2004-11-22 2012-02-15 Anadis Ltd. Bioactive compositions
NZ575918A (en) 2006-08-31 2012-03-30 A C N 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and/or prevention of non-infectious medical conditions using antibody-containing milk or egg products
NZ587901A (en) 2008-03-13 2012-11-30 Immuron Ltd Immuno-modulating compositions for the treatment of immune-mediated disorders
BRPI1014774A2 (pt) * 2009-04-27 2019-04-16 Immuron Limited preparacao de imunoglobulina enriquecida anti-lps para uso no tratamento e/ou na profilaxia de um disturbio patologico

Also Published As

Publication number Publication date
US20130224216A1 (en) 2013-08-29
ES2628032T3 (es) 2017-08-01
EP2605791B1 (en) 2017-03-08
WO2012023051A3 (en) 2012-04-26
AU2011290478A1 (en) 2013-02-28
CA2808361A1 (en) 2012-02-23
DK2605791T3 (en) 2017-06-19
WO2012023051A9 (en) 2012-06-14
AU2011290478B2 (en) 2014-11-13
WO2012023051A2 (en) 2012-02-23
US9943597B2 (en) 2018-04-17
EP2605791A2 (en) 2013-06-26

Similar Documents

Publication Publication Date Title
HK1185016A1 (zh) 用於治療和/或預防病理病症的富集有抗 的免疫球蛋白的製劑
IL215924A0 (en) Anti-lps enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder
EP2401001A4 (en) ANTI-INFECTIOUS FUNCTIONALIZED SURFACES AND MANUFACTURING METHOD
IL238573A0 (en) Identification of cyclic defects in media flows
EP2522002A4 (en) DETERMINING A TIME ZONE AND PASSING AT SUMMER TIME
IL232609A0 (en) Root devices and methods for their production
EP2638534A4 (en) ENHANCEMENT OF COGNITION IN THE PRESENCE OF DISTRACTION AND / OR INTERRUPTION
EP2701621A4 (en) METHODS AND INSTRUMENTS FOR USE IN VERTEBRAL TREATMENT
EP2797561A4 (en) ORAL APPARATUS AND METHODS OF USE
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2670434A4 (en) TREATMENT OF TAUOPATHIA
HK1258530A1 (zh) Serpina 1 sirnas:物質的組合物和治療方法
EP2769350A4 (en) EMBOSSING AND USE OF DIGITAL MONEY
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
EP2688557A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER
EP2490715A4 (en) NEW DOSAGE ADMINISTRATION REGIMEN AND METHOD OF TREATMENT
EP2697974A4 (en) METHODS AND DEVICES FOR ENCODING AND DECODING THE POSITION OF THE LAST SIGNIFICANT COEFFICIENT
EP2661746A4 (en) MULTI-CHANNEL CODING AND / OR DECODING
EP2528938A4 (en) PROANGIOGENIC FRAGMENTS OF PROMININ 1 AND USES THEREOF
HK1196289A1 (zh) 用於敗血症的治療和/或改善的藥物
PL2757910T3 (pl) Produkt z mieszanego włókna do stosowania przy wytwarzaniu elementów filtracyjnych papierosa i odnośne sposoby
GB201002083D0 (en) Apparatus for improving and/or maintaining numerical ability
GB2493209B (en) Method and device for parallel decoding of scalable bitstream elements
HK1208130A1 (zh) 延長釋放左乙拉西坦和製備方法
HK1254929A1 (zh) 增強的天然甜味劑以及製備方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210817